We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.9B
AUM Growth
-$1.05B
Cap. Flow
-$1.27B
Cap. Flow %
-3.76%
Top 10 Hldgs %
9.76%
Holding
1,528
New
93
Increased
461
Reduced
505
Closed
116

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$50.1M
2
GCO icon
Genesco
GCO
+$46.4M
3
DAN icon
Dana Inc
DAN
+$41.3M
4
KW
Kennedy-Wilson Holdings
KW
+$31.1M
5
JBTM
JBT Marel
JBTM
+$30.8M

Sector Composition

Rank Sector Weight
1 Industrials 24.41%
2 Technology 17.65%
3 Consumer Discretionary 14.64%
4 Financials 10.23%
5 Materials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THO icon
1
Thor Industries
THO
$3.97B
$444M 1.31%
7,266,822
-259,300
-3% -$14.4M
UNT
2
DELISTED
UNIT Corporation
UNT
$399M 1.18%
6,102,323
-809,037
-12% -$45M
RS icon
3
Reliance Steel & Aluminium
RS
$20B
$384M 1.13%
5,429,612
+87,640
+2% +$6.25M
FHI icon
4
Federated Hermes
FHI
$4.84B
$380M 1.12%
12,450,264
+109,920
+0.9% +$3.08M
BKE icon
5
Buckle
BKE
$2.21B
$351M 1.04%
7,674,629
-169,976
-2% -$7.75M
MYGN icon
6
Myriad Genetics
MYGN
$304M
$323M 0.95%
9,435,713
-1,407,362
-13% -$43.6M
LECO icon
7
Lincoln Electric
LECO
$15.8B
$263M 0.78%
3,652,253
-239,733
-6% -$17.2M
MTX icon
8
Minerals Technologies
MTX
$2.25B
$259M 0.77%
4,018,349
-122,240
-3% -$6.91M
HP icon
9
Helmerich & Payne
HP
$4.24B
$252M 0.75%
2,347,007
-575,793
-20% -$53.5M
UNF icon
10
Unifirst Corp
UNF
$5.17B
$250M 0.74%
2,275,350
+1,650
+0.1% +$179K
VMI icon
11
Valmont Industries
VMI
$9.28B
$246M 0.73%
1,655,040
+93,405
+6% +$13.8M
MKSI icon
12
MKS Inc
MKSI
$18.3B
$240M 0.71%
8,019,000
+34,800
+0.4% +$1.04M
Y
13
DELISTED
Alleghany Corp
Y
$237M 0.7%
581,513
ZBRA icon
14
Zebra Technologies
ZBRA
$17.1B
$221M 0.65%
3,177,181
-152,500
-5% -$9.35M
POLY
15
DELISTED
Plantronics, Inc.
POLY
$219M 0.65%
4,917,809
+361,649
+8% +$16M
RBA icon
16
RB Global
RBA
$15.9B
$218M 0.64%
9,048,367
+343,913
+4% +$7.89M
WLK icon
17
Westlake Corp
WLK
$9.45B
$211M 0.62%
3,189,436
-857,000
-21% -$54.5M
ENS icon
18
EnerSys
ENS
$6.89B
$209M 0.62%
3,009,880
-227,592
-7% -$16M
AVX
19
DELISTED
AVX Corporation
AVX
$204M 0.6%
15,511,784
+1,257,101
+9% +$16.4M
MATV icon
20
Mativ Holdings
MATV
$672M
$199M 0.59%
4,671,951
-7,354
-0.2% -$336K
TER icon
21
Teradyne
TER
$58.2B
$196M 0.58%
9,842,678
-4,186,386
-30% -$81M
WWD icon
22
Woodward
WWD
$20.4B
$193M 0.57%
4,638,524
CBT icon
23
Cabot Corp
CBT
$4.37B
$188M 0.56%
3,191,193
+47,600
+2% +$2.5M
VSH icon
24
Vishay Intertechnology
VSH
$4.87B
$185M 0.55%
12,414,476
-426,348
-3% -$5.99M
AIT icon
25
Applied Industrial Technologies
AIT
$12.4B
$183M 0.54%
3,788,681
-216,318
-5% -$10.6M

Similar funds

Royce & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.

  • Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
  • Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
  • Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
  • Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
  • Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
  • Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
  • Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.